Tianjin TEDA Biomedical Engineering Company Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 124.407 million compared to CNY 68.523 million a year ago. Net loss was CNY 165,625 compared to CNY 5.591 million a year ago. Basic loss per share from continuing operations was CNY 0.00009 compared to CNY 0.00295 a year ago.